TG Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TG Therapeutics, Inc. (TGTX) on April 12, 2021. The report discloses a change in the Company's independent registered public accounting firm.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance regarding the audit firm.
Material Changes
- Dismissal of Auditor: On April 12, 2021, the Audit Committee unanimously voted to dismiss CohnReznick LLP as the independent registered public accounting firm.
- Engagement of New Auditor: KPMG LLP was engaged as the independent registered public accounting firm for the 2021 fiscal year.
- Audit History: CohnReznick's reports for fiscal years ended December 31, 2020, and 2019, contained no adverse opinions, disclaimers, or qualifications.
- No Disagreements: There were no disagreements with CohnReznick regarding accounting principles, practices, financial statement disclosure, or auditing scope during the relevant periods.
- No Reportable Events: No reportable events occurred under Item 304(a)(1)(v) of Regulation S-K during the tenure of CohnReznick or the subsequent period.
- Consultation with New Auditor: The Company did not consult with KPMG regarding accounting principles, audit opinions, disagreements, or reportable events prior to engagement.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, management commentary on operations, or specific risk factors beyond the standard disclosure of the auditor change. The Company provided CohnReznick with a copy of this Form 8-K and requested a letter addressed to the SEC confirming agreement with the statements made, which is attached as Exhibit 16.1.
Key Facts for Investor Verification
- Verify the content of the letter from CohnReznick LLP (Exhibit 16.1) to confirm they agree with the Company's statements regarding the dismissal.
- Confirm the effective date of KPMG LLP's engagement for the 2021 fiscal year.
- Review subsequent filings to ensure no undisclosed disagreements or reportable events emerged post-filing.